New cycloAmb-nucleoside phosphonate prodrugs

Nucleosides, Nucleotides and Nucleic Acids

Volumn 26, Issue 6-7, 2007, Pages 831-834

  Gorbig U ^a   Balzarini, J ^b   Meier, C ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral activity; Benzyl cation; Hydrolysis; Nucleoside phosphonates; Phenylphosphate diester; Prodrugs

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; CIDOFOVIR; PRODRUG; TENOFOVIR;

BIOLOGICAL ACTIVITY; CONFERENCE PAPER; DRUG HALF LIFE; DRUG SYNTHESIS; HYDROLYSIS;

HYDROLYSIS; NUCLEOSIDES; PHOSPHONIC ACIDS; PRODRUGS;

EID: 36949002046     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770701503894     Document Type: Conference Paper

References (6)

1. Starrett, Jr., J.E.; Tortolani, D.R.; Russell, J.,; Hitchcock, M.J.M.; Whiterock, V.; Martin, J.C.; Mansuri, M.M. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA). J. Med. Chem. 1994, 37, 1857-1864.
2. Benzaria, S.; Pelicano, H.; Johnson, R.; Maury, G.; Imbach, J.-L.; Aubertin, A-M.; Obert, G.; Gosselin, G. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability. J. Med. Chem. 1996, 39, 4958-4965.
3. Meier, C. Pro-nucleotides-Recent advances in the design of efficient tools. Synlett 1998, 1, 233-242.
4. Meier, C. cycloSal-pronucleotides-Design of chemical trojan horses. Mini Rev. Med. Chem. 2002, 2, 219-234.
5. Meier, C.; Görbig, U.; Müller, C.; Balzarini, J. cycloSal-PMEA and cycloAmb-PMEA: Potentially new phosphonate prodrugs based on the cycloSal-pronucleotide approach. J. Med. Chem. 2005, 48, 8079-8086.
6. Meier, C.; Renze, J.T.; Balzarini, J.; De Clercq, E. d4TMP delivery from 7-substituted cycloSal-d4TMPs. Nucleosides & Nucleotides 2003, 22, 825-827.